• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Efficacy and Safety of Repeated Ketamine Infusion in Treatment Resistant Depression

    Dr. Vijay Kumar Saini, Dr. KK Verma, Dr. Pratibha Gehlawat, Dr. Shrigopal Goyal, Dheeraj Goya, Dhanu Saini

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 5540-5550

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction:  Ketamine infusion was known to be effective treatment in treatment resistant depressed patients in subanasthetic dose as shown by multiple studies. Previous studies suggested that repeated infusion having higher response rate than single infusion.With this rationale, we planned a study a study to see efficacy and safety of  repeated infusion in such patients.
Methods and Materials: 
This was a single center, prospective, open-label study . After applying inclusion and exclusion criteria 20 patients were recruited and ketamine was infused @ 0.5mg/kg over 60 min under guidance of anaesthetist.Various scales like MADRS , CGI,SSI,BPRS and CADSS were applied to see efficacy and safety of infusion before and after every infusion and mean scores were compared with appropriate statistics.
Results and Conclusions:  
In our study, 14 patients (70%) showed response among 20 patients, among responders 10 patient (50%) were remitters. Pre and Post infusion difference between mean MADRS, CGI and SSI scores found signicant while difference between mean BPRS and CADSS scores were not significant.  Most of the patient felt self limiting side effect like sedation, dizziness, vertigo, restlessness etc. So ketamine infusion is safer alternative for treatment resistant depression.
Keywords:
  • PDF (254 K)
  • XML
(2022). Efficacy and Safety of Repeated Ketamine Infusion in Treatment Resistant Depression. European Journal of Molecular & Clinical Medicine, 9(3), 5540-5550.
Dr. Vijay Kumar Saini, Dr. KK Verma, Dr. Pratibha Gehlawat, Dr. Shrigopal Goyal, Dheeraj Goya, Dhanu Saini. "Efficacy and Safety of Repeated Ketamine Infusion in Treatment Resistant Depression". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 5540-5550.
(2022). 'Efficacy and Safety of Repeated Ketamine Infusion in Treatment Resistant Depression', European Journal of Molecular & Clinical Medicine, 9(3), pp. 5540-5550.
Efficacy and Safety of Repeated Ketamine Infusion in Treatment Resistant Depression. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 5540-5550.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 65
  • PDF Download: 124
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus